Canadian Agency for Drugs and Technologies in Health. (2016). Point-of-care troponin testing in patients with symptoms suggestive of acute coronary syndrome Recommendations. Canadian Agency for Drugs and Technologies in Health.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Point-of-care Troponin Testing in Patients with Symptoms Suggestive of Acute Coronary Syndrome Recommendations. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2016.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Point-of-care Troponin Testing in Patients with Symptoms Suggestive of Acute Coronary Syndrome Recommendations. Canadian Agency for Drugs and Technologies in Health, 2016.
Warning: These citations may not always be 100% accurate.